Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
IFN-gamma and TNF-alpha, potent inhibitors of hematopoiesis, induce nitric oxide synthase (NOS) in various cell types. When normal human bone marrow (BM) or CD34+ cells were exposed to NO, inhibition of colony formation was dose dependent and direct. NO induced apoptosis in BM progenitors, as shown by electrophoretic detection of DNA degradation and deoxynucleotidyl transferase assay. Using PCR and immunoprecipitation, we found inducible NOS (iNOS) mRNA and iNOS protein in BM after stimulation with IFN-gamma or TNF-alpha. iNOS mRNA was also detected by PCR in highly purified CD34+ cells; TNF-alpha or IFN-gamma increased iNOS expression. The presence of iNOS in CD34+ cells was confirmed in single cells by immunochemical staining. NG-Monomethyl-L-arginine (MM-Arg), an NOS inhibitor, partially reversed the effects of TNF-alpha and, to a lesser extent, IFN-gamma in methylcellulose culture of total BM and CD34+ cells, and inhibited apoptosis of BM cells induced by these cytokines. When the effects of competitive iNOS inhibition were tested on more immature progenitors, MM-Arg increased the number of long-term BM culture-initiating cells in control cultures but failed to protect these cells from the inhibitory action of IFN-gamma and TNF-alpha. Our results suggest that NO may be one mediator of cytokine-induced hematopoietic suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, a range of inflammatory mediators including TNF, IL-1, IFN-γ, and reactive intermediates inhibits the proliferation and differentiation of erythroid progenitors or induces their apoptosis [91–94].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350 · cited 2×
“Nitric oxide (NO),' a radical produced in mammalian cells from arginine in a reaction catalyzed by nitric oxide synthase (NOS), has pleiotropic biologic activities (1-3).”
BackgroundSelf-citationDing, A. H., Nathan, C. F., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,826
Self-citationBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Self-citationCloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Self-citationRedox signaling: Nitrosylation and related target interactions of nitric oxide
Stamler, J. S. (1994) · Cell · doi:10.1016/0092-8674(94)90269-0 · Cited by 1,723
Role of nitric oxide synthesis in macrophage antimicrobial activity
Nathan, C. F., & Hibbs, J. B. (1991) · Current Opinion in Immunology · doi:10.1016/0952-7915(91)90079-g · Cited by 1,523
Self-citationStamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.444 · Cited by 1,471
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
The role of nitric oxide in inflammatory reactions: Nitric oxide: control of immune response
Tripathi, P., Tripathi, P., Kashyap, L., & Singh, V. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00329.x · Cited by 511
RetractedThe Pathophysiology of Acquired Aplastic Anemia
Young, N. S., & Maciejewski, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705083361906 · Cited by 505
Self-citationIron, anaemia, and inflammatory bowel diseases
Gasche, C., Lomer, M. C. E., Cavill, I., & Weiss, G. (2004) · Gut · doi:10.1136/gut.2003.035758 · Cited by 494
Iron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322
“radicals such as nitric oxide (NO) or superoxide anion contribute to the inhibition of erythroid progenitor cell proliferation [25].”
BackgroundHuman malarial disease: a consequence of inflammatory cytokine release
Clark, I. A., Budd, A. C., Alleva, L. M., & Cowden, W. B. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-85 · Cited by 317
Nitric Oxide Inhibits Fas-induced Apoptosis
Mannick, J. B., Miao, X. Q., & Stamler, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24125 · Cited by 315
Modulation of Cytokine-Induced Cardiac Myocyte Apoptosis by Nitric Oxide, Bak, and Bcl-x
Ing, D. J., Zang, J., Dzau, V. J., Webster, K. A., & Bishopric, N. H. (1999) · Circulation Research · doi:10.1161/01.res.84.1.21 · Cited by 282
Pathogenesis and treatment of anaemia of chronic disease
Weiss, G. (2002) · Blood Reviews · doi:10.1054/blre.2002.0193 · Cited by 277
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
van der Putten, K., Braam, B., Jie, K. E., & Gaillard, C. A. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0655 · Cited by 180
“80 Lawrence CM et al. (1999) Crystal structure of the ectodomain of human transferrin receptor.”
BackgroundInfluentialAngulo, I., de las Heras, F. G., Garcı́a-Bustos, J. F., Gargallo, D., Muñoz-Fernández, M. A., & Fresno, M. (2000) · Blood · doi:10.1182/blood.v95.1.212 · Cited by 161
Regulation of Hematopoiesis by Microvascular Endothelium
Rafii, S., Mohle, R., Shapiro, F., Frey, B. M., & Moore, M. A. S. (1997) · Leukemia & Lymphoma · doi:10.3109/10428199709058305 · Cited by 169
Van 't Hof, R. J., & Ralston, S. H. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1797 · Cited by 166
“In agreement with our data, high levels of IFN-g and TNF-a induced NO have been shown to inhibit proliferation of human bone marrow cells,((16)) and this inhibitory effect has been partially attributed to NO-induced apoptosis.((17)) The fact that cytokines reduced apoptosis in bone marrow cell monocultures may be attr…”
ResultRathbun, R. K., Faulkner, G. R., Ostroski, M. H., Christianson, T. A., Hughes, G., Jones, G., Cahn, R., Maziarz, R., Royle, G., Keeble, W., et al. (1997) · Blood · doi:10.1182/blood.v90.3.974 · Cited by 143
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Mátyás, C., Haskó, G., Liaudet, L., Trojnár, E., & Pacher, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0433-5 · Cited by 174
Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia
Young, N. S. (2000) · Seminars in Hematology · doi:10.1016/s0037-1963(00)90026-x · Cited by 146
Self-citationGoldstein, L. J., Gallagher, K. A., Bauer, S. M., Bauer, R. J., Baireddy, V., Liu, Z., Buerk, D. G., Thom, S. R., & Velazquez, O. C. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0010 · Cited by 128
Fauconnier, J., Méli, A. C., Thireau, J., Roberge, S., Shan, J., Sassi, Y., Reiken, S. R., Rauzier, J.-M., Marchand, A., Chauvier, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100286108 · Cited by 138
“Several studies have reported that TNF-α increases NO production either acutely through ceramide production and eNOS activation (12) or after induction of iNOS expression (19).”
BackgroundNitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation
Weinberg, J. B. (2000) · Immunologic Research · doi:10.1385/ir:22:2-3:319 · Cited by 121
Zeng, W., Miyazato, A., Chen, G., Kajigaya, S., Young, N. S., & Maciejewski, J. P. (2006) · Blood · doi:10.1182/blood-2005-05-1884 · Cited by 121
““Absolute” expression levels (in arbitrary fluorescence units [AFUs]) are indicated using a color scale; red bars indicate high level of expression ( 1000 AFU); yellow bars, medium level of expression (200-1000 AFU); green bars, low level (20-200).”
Self-citationNitric oxide and immune response.
Tripathi, P. (2007) · PubMed · Cited by 111
Iron and anemia of chronic disease
Weiß, G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69012.x · Cited by 117
Anaemia of cancer: an overview of mechanisms involved in its pathogenesis
Grotto, H. (2008) · Medical Oncology · doi:10.1007/s12032-007-9000-8 · Cited by 112
“Other studies reported that erythropoiesis may be directly blocked by NO, which could inhibit the proliferation of erythroid progenitors [ 45 , 46].”
BackgroundPathophysiology of anemia and erythrocytosis
Hodges, V. M., Rainey, S., Lappin, T. R. J., & Maxwell, A. P. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.06.006 · Cited by 133
“itrogen free radicals, which can directly damage progenitor ells [144].”
BackgroundOxidative Stress and the Myelodysplastic Syndromes
Farquhar, M. J., & Bowen, D. (2003) · International Journal of Hematology · doi:10.1007/bf02982641 · Cited by 96
“Normal bone marrow cells or CD34 + cells exposed to NO produced a dose-dependent inhibition of progenitor colony formation [ 72 ].”
BackgroundThe Michael Mason Prize Essay 1997. Nitric oxide and bone: what a gas!
Ralston, S. H. (1997) · Rheumatology · doi:10.1093/rheumatology/36.8.831 · Cited by 97
“Whilst apoptotic effects of NO are recognized to occur in other cell types [67], an interesting facet of NO-induced apoptosis in bone is the relative selectivity for osteoclast progenitors, rather than mature osteoclasts or osteoblasts.”
BackgroundAnemia of chronic disease: A unique defect of iron recycling for many different chronic diseases
Poggiali, E., Amicis, M. M. D., & Motta, I. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.07.011 · Cited by 118
“Moreover, cytokines, including IFN-γ and TNF-α, may directly damage the erythroid progenitors by inducing the formation of labile free radicals, such as nitric oxide or superoxide anion [32], decreasing erythrocyte half-life and promoting erythrophagocytosis [33].”
BackgroundAplastic anemia: Pathophysiology
Giudice, V., & Selleri, C. (2022) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.12.002 · Cited by 112
Self-citationSato, T., Selleri, C., Young, N. S., & Maciejewski, J. P. (1997) · Blood · doi:10.1182/blood.v90.12.4749 · Cited by 93
Self-citationJun, C., Oh, C., Kwak, H. J., Pae, H., Yoo, J.-C., Choi, B., Chun, J., Park, R., & Chung, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3395 · Cited by 102
Activation of the Endothelial Nitric-oxide Synthase by Tumor Necrosis Factor-α
Bulotta, S., Barsacchi, R., Rotiroti, D., Borgese, N., & Clementi, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006535200 · Cited by 92
Shami, P., & Weinberg, J. (1996) · Blood · doi:10.1182/blood.v87.3.977.bloodjournal873977 · Cited by 97
James, S., Williams, M., Newland, A. C., & Colston, K. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00098-6 · Cited by 88
Smržová, J., Balla, J., & Barany, P. F. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1109 · Cited by 83
“These marked inhibitory effects of IFN-g and TNF-a on erythroid progenitor cells might be related to the ability of these cytokines to generate nitric oxide (NO) [22], a substance that is known to suppress the proliferation of erythroid progenitor cells.”
BackgroundNitric Oxide Is a Regulator of Hematopoietic Stem Cell Activity
Michurina, T. V., Krasnov, P. A., Balazs, A. B., Nakaya, N., Vasilieva, T. V., Ba, K., Khrushchov, N. G., Mulligan, R. C., & Enikolopov, G. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.030 · Cited by 75
Iron and the anemia of chronic disease.
Spivak, J. L. (2002) · PubMed · Cited by 91
Visse, E., Siesjö, P., Widegren, B., & Sjögren, H. O. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700023 · Cited by 69
Nitric oxide induces apoptosis in megakaryocytic cell lines
Battinelli, E. M., & Loscalzo, J. (2000) · Blood · doi:10.1182/blood.v95.11.3451 · Cited by 72
Secchiero, P., Gonelli, A., Celeghini, C., Mirandola, P., Guidotti, L., Visani, G., Capitani, S., & Zauli, G. (2001) · Blood · doi:10.1182/blood.v98.7.2220 · Cited by 71
Cifone, M. G., D’Alò, S., Parroni, R., Millimaggi, D., Biordi, L., Martinotti, S., & Santoni, A. (1999) · Blood · doi:10.1182/blood.v93.11.3876 · Cited by 64
Anstey, N. M., Granger, D. L., Hassanali, M. Y., Mwaikambo, E. D., Duffy, P. E., & Weinberg, J. B. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.249 · Cited by 66
Jun, C., Pae, H., Kwak, H. J., Yoo, J.-C., Choi, B., Oh, C., Chun, J., Paik, S., Park, Y., & Chung, H. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1480 · Cited by 61
Luo, Y., Shao, L., Chang, J., Feng, W., Liu, Y. L., Cottler‐Fox, M., Emanuel, P. D., Hauer‐Jensen, M., Bernstein, I. D., Liu, L., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018015685 · Cited by 63
“In addition, exposure to NO induces HSC and HPC apoptosis.(25) In contrast, polyamines, such as spermidine synthesized through the arginine metabolic pathway initiated by Arg1, have the potential to promote HSC self-renewal via stimulation of autophagy.”
BackgroundThe Heme-regulated Eukaryotic Initiation Factor 2α Kinase
Uma, S., Yun, B.-G., & Matts, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011476200 · Cited by 61
Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture
Reykdal, S., Abboud, C. N., & Liesveld, J. L. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00030-7 · Cited by 55
Papadaki, H. Α., Σταματόπουλος, Κ., Damianaki, A., Gemetzi, C., Anagnostopoulos, Α., Papadaki, T., Eliopoulos, A. G., & Eliopoulos, G. D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05380.x · Cited by 65
“…by patient lymphocytes as well as by the activated state of PB and BM cytotoxic lymphocytes, has been implicated in the immune suppression of haemopoiesis associated with aplastic anaemia (Maciejewski et al, 1995, Young, 2000b) and myelodysplastic syndromes (Dunbar & Saunthararajah, 2000).”
BackgroundShima, Y., Maeda, T., Aizawa, S., Tsuboi, I., Kobayashi, D., Kato, R., & Tamai, I. (2005) · Blood · doi:10.1182/blood-2005-08-3166 · Cited by 54
Pourfarzad, F., Lindern, M. V., Azarkeivan, A., Hou, J., Kia, S. K., Esteghamat, F., van IJcken, W. F. J., Philipsen, S., Najmabadi, H., & Grosveld, F. G. (2012) · Haematologica · doi:10.3324/haematol.2012.074492 · Cited by 54
Lee, S., Kim, J., Lee, H., Cho, Y.-S., Oh, S.-H., Kim, Y.-J., Jung, C.-H., Zhang, W., & Lee, J.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206133 · Cited by 57
“IFNs are a family of multifunctional cytokines that trigger immunomodulatory, antiviral, antiproliferative, and antitumor activities (Deiss et al., 1995; Maciejewski et al., 1995; De Maeyer and De MaeyerGuignard, 1998).”
BackgroundAnemia of Chronic Disease (Anemia of Inflammation)
Agarwal, N., & Prchal, J. T. (2009) · Acta Haematologica · doi:10.1159/000243794 · Cited by 67
“IFN-γ and TNF-α induce nitric oxide synthase and generate nitric oxide, which inhibits erythropoiesis in a dose-dependent fashion. However, the pathophysiology of anemia of inflammation is not fully elucidated, as suggested by the related condition, ‘anemia of aging’ , wherein anemia is not associated with increased h…”
BackgroundBrittenham, G., Weiss, G., Brissot, P., Lainé, F., Guillygomarc’h, A., Guyader, D., Moirand, R., & Deugnier, Y. (2000) · Hematology · doi:10.1182/asheducation-2000.1.39 · Cited by 66
Selleri, C., Sato, T., Raiola, A. M., Rotoli, B., Young, N. S., & Maciejewski, J. P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4323240.x · Cited by 53
“In previous studies (Maciejewski et al, 1995b), IFN-g- and TNF-a-mediated suppression of haemopoiesis could be partially prevented by a competitive inhibitor of iNOS, gMMArg.”
BackgroundMethodResultInfluentialSelf-citationFunctional Aspects of Apoptosis in Hematopoiesis and Consequences of Failure
McKenna, S. L., & Cotter, T. G. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60098-6 · Cited by 54
Mohan, & Stevenson (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01126.x · Cited by 52
Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death
Kim, B., Yoon, K., Oh, H., Choi, E., Kim, S., Han, W., Kim, E.-A. L., Choi, S. C., Kim, T., Yun, K., et al. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(03)00031-5 · Cited by 50
Kwak, H. J., Jun, C.-D., Pae, H., Yoo, J.-C., Park, Y.-C., Choi, B.-M., Na, Y. G., Park, R., Chung, H.-T., Chung, H. Y., et al. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1309 · Cited by 50
Anemia in Heart Failure Patients
Alexandrakis, M. G., & Tsirakis, G. (2012) · ISRN Hematology · doi:10.5402/2012/246915 · Cited by 55
“Paralleling these cardiodepressive actions, NO seems to have a direct inhibitory effect on bone marrow hematopoietic activity [55, 56].”
BackgroundSato, T., Selleri, C., Young, N. S., & Maciejewski, J. P. (1995) · Blood · doi:10.1182/blood.v86.9.3373.bloodjournal8693373 · Cited by 47
Self-citationRafferty, S. P., Domachowske, J., & Malech, H. L. (1996) · Blood · doi:10.1182/blood.v88.3.1070.1070 · Cited by 48
Wang, Q., Luo, W., Zhang, W., Dai, Z., Chen, Y., & Chen, J. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.04.004 · Cited by 43
“DNA samples, 10 mg each, were subjected to electrophoresis on a 1.4% agarose at 50 V for 3 h and stained with ethidium bromide and the pattern of DNA cleavage was analyzed as described (Maciejewski et al., 1995).”
MethodInfluentialHematopoietic stem cells in aplastic anemia
Maciejewski, J. P., & Risitano, A. M. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.09.009 · Cited by 41
Self-citationGyan, B. A., Kurtzhals, J. A. L., Akanmori, B. D., Ofori, M. F., Goka, B. Q., Hviid, L., & Behr, C. (2002) · Acta Tropica · doi:10.1016/s0001-706x(02)00109-2 · Cited by 43
Nacher, M., Singhasivanon, P., Gay, F., Phumratanaprapin, W., Silachamroon, U., & Looareesuwan, S. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.65.335 · Cited by 40
Koistinen, P., Siitonen, T., Mäntymaa, P., Säily, M., Kinnula, V. L., Savolainen, E.-R., & Soini, Y. (2001) · Leukemia · doi:10.1038/sj.leu.2402217 · Cited by 40
Functional and molecular characterization of NOS isoforms in rat neutrophil precursor cells
Kumar, S., Jyoti, A., Keshari, R. S., Singh, M. P., Barthwal, M. K., & Dikshit, M. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20852 · Cited by 38
Kitagawa, M., Takahashi, M., Yamaguchi, S., Inoue, M., Ogawa, S., Hirokawa, K., & Kamiyama, R. (1999) · Leukemia · doi:10.1038/sj.leu.2401407 · Cited by 38
The Role of Nitric Oxide in the Regulation of Cellular Iron Metabolism
Domachowske, J. B. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1996.2557 · Cited by 41
Domachowske, J. B., Rafferty, S. P., Singhania, N., Mardiney, M. R., & Malech, H. L. (1996) · Blood · doi:10.1182/blood.v88.8.2980.bloodjournal8882980 · Cited by 38
Jalnapurkar, S. S., Moirangthem, R. D., Singh, S., Limaye, L. S., & Kale, V. P. (2018) · Stem Cells · doi:10.1002/stem.2912 · Cited by 37
Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
Fattizzo, B., Serpenti, F., Barcellini, W., & Caprioli, C. (2021) · Cancers · doi:10.3390/cancers13010132 · Cited by 45
Dugas, N., Mossalayi, M. D., Calenda, A., Leotard, A., Bécherel, P., Mentz, F., Ouaaz, F., Arock, M., Debré, P., Dornand, J., et al. (1996) · Blood · doi:10.1182/blood.v88.9.3528.bloodjournal8893528 · Cited by 37
Chapter 7 Effects of Nitric Oxide on Red Blood Cell Development and Phenotype
Čokić, V. P., & Schechter, A. N. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00007-5 · Cited by 38
Choi, B.-M., Park, R., Pae, H., Yoo, J.-C., Kim, Y., Jun, C., Jung, B., Oh, G., So, H., Kim, J., et al. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.d01-10.x · Cited by 36
Farsky, S. H. P., Borelli, P., Fock, R. A., Proto, S., Ferreira, J., & de Mello, S. B. V. (2004) · Inflammation Research · doi:10.1007/s00011-004-1288-7 · Cited by 35
“Additionally, erythroid and myeloid progenitor cells appear to have differential sensitivity to NO [63, 64 ].”
BackgroundKoh, P. S., Hughes, G. C., Faulkner, G. R., Keeble, W. W., & Bagby, G. C. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00064-2 · Cited by 35
“In view of the Fas dependence of IFNg hypersensitivity in FAC nullizygous HPC and the recent findings of Broxmeyer’s group that FAC 2 / 2 cells are hypersensitive to TNFa [57], another mediator of bone marrow suppression and programmed cell death [29,58,59], we hypothesized that, in addition to Fas, IFNg may induce ex…”
ResultTatemichi, M., Ogura, T., Nagata, H., & Esumi, H. (1998) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199810000-00012 · Cited by 36
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature
Giudice, V., Cardamone, C., Triggiani, M., & Selleri, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020705 · Cited by 37
“BM growth is also reduced because of increased apoptosis through induction of Fas expression on HSPCs, which facilitates apoptosis via Fas/Fas ligand (FasL), and by inducing nitric oxide synthase (NOS) and production of nitric oxide [30,32].”
BackgroundSelf-citationImmunology of human schistosomiasis: off the beaten path
Secor, W. E. (2005) · Parasite Immunology · doi:10.1111/j.1365-3024.2005.00778.x · Cited by 31
Iron homeostasis in chronic inflammation
Balla, J., Jeney, V., Varga, Z., Komódi, E., Nagy, E., & Balla, G. (2007) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.94.2007.1-2.9 · Cited by 39
Nunes, A. R., & Tata, M. (2017) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2016.12.005 · Cited by 47
Aksöz, M., Albayrak, E., Aslan, G. S., Turan, R. D., Alyazici, L. Y., Siyah, P., Tüysüz, E. C., Canikyan, S., Yücel, D., Meriç, N., et al. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180905100608 · Cited by 31
[Anemia and inflammatory bowel disease].
de la Morena, F., & Gisbert, J. P. (2008) · PubMed · Cited by 37
Neuronal Nitric Oxide Synthase Contributes to the Regulation of Hematopoiesis
Krasnov, P. A., Michurina, T. V., Packer, M. A., Stasiv, Y., Nakaya, N., Moore, K. A., Drazan, K. E., & Enikolopov, G. (2008) · Molecular Medicine · doi:10.2119/2007-00011.krasnov · Cited by 32
Chu, L., Jiang, Y., Hao, H., Xia, Y., Xu, J., Liu, Z., Verfaillie, C. M., Zweier, J. L., & Liu, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.066 · Cited by 32
“NO has been reported to be involved in endothelial progenitor cell growth and differentiation (Maciejewski et al., 1995; Reykdal et al., 1999).”
BackgroundATTENUATION OF LETHAL GRAFT-VERSUS-HOST DISEASE BY INHIBITION OF NITRIC OXIDE SYNTHASE1
Hoffman, R. A., ssler, N. C. N., Gleixner, S. L., Zhang, G., Ford, H. R., Langrehr, J. M., Demetris, A. J., & Simmons, R. L. (1997) · Transplantation · doi:10.1097/00007890-199701150-00018 · Cited by 34
Jun, C., Park, S., Choi, B., Kwak, H. J., Park, Y.-C., Kim, M., Park, R., & Chung, H. (1997) · Cellular Immunology · doi:10.1006/cimm.1996.1064 · Cited by 31
Ferry‐Dumazet, H., Mamani‐Matsuda, M., Dupouy, M., Belloc, F., Thiolat, D., Marit, G., Arock, M., Reiffers, J. J., & Mossalayi, M. D. (2002) · Leukemia · doi:10.1038/sj.leu.2402404 · Cited by 32
Holt, D., Ryder, T., Fairbairn, A., Hurley, R., & Harvey, D. J. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701601004 · Cited by 30
Selleri, C., Maciejewski, J. P., Montuori, N., Ricci, P., Visconte, V., Serio, B., Luciano, L., & Rotoli, B. (2003) · Blood · doi:10.1182/blood-2003-01-0178 · Cited by 30
Self-citationCD23/FcεRII: Signaling and Clinical Implication
Mossalayi, M. D., Arock, M., & Debré, P. (1997) · International Reviews of Immunology · doi:10.3109/08830189709045706 · Cited by 29
Anaemia in chronic obstructive pulmonary disease: an insight into its prevalence and pathophysiology
Boutou, A., Hopkinson, N. S., & Polkey, M. I. (2014) · Clinical Science · doi:10.1042/cs20140344 · Cited by 34
Wang, C., Hsieh, W.-Y., Shih, L., Lin, H., Liu, C., Chung, K. F., & Kuo, H.-P. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70291-5 · Cited by 30
Angulo, I., Jiménez-Dı́az, M. B., Garcia-Bustos, J., Gargallo, D. V., Heras, F. G. D. L., Muñoz‐Fernández, M. Á., & Fresno, M. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00521-x · Cited by 28
Immune pathophysiology of acquired aplastic anaemia
Young, N. S. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01646.x · Cited by 28
Self-citationImmunological derangement in Hypocellular Myelodysplastic Syndromes
Serio, B., Risitano, A., Giudice, V., Montuori, N., & Selleri, C. (2014) · Europe PMC (PubMed Central) · doi:10.14273/unisa-230 · Cited by 27
Self-citationNitric oxide donors suppress erythropoietin production in vitro
Schobersberger, W., HOFFMANN, G. E., & Fandrey, J. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050225 · Cited by 27
“strong inhibitors of erythrocytic progenitor growth and development [21, 22, 28].”
BackgroundMalnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease
Rao, P., Reddy, G. C., & Kanagasabapathy, A. S. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0048-9 · Cited by 30
Anemia in the Elderly Population
Bianchi, V. E. (2014) · Journal of Hematology · doi:10.14740/jh182w · Cited by 33
“IFN-γ and TNF-α, potent inhibitors of hematopoiesis, induce nitric oxide synthase in various cell types, and nitric oxide may be one mediator of cytokine-induced hematopoietic suppression [129].”
BackgroundInflammation and anaemia in a broad spectrum of patients with heart failure
Kleijn, L., Belonje, A. M. S., Voors, A. A., de Boer, R. A., Jaarsma, T., Ghosh, S., Kim, J., Hillege, H. L., van Gilst, W. H., van Veldhuisen, D. J., et al. (2012) · Heart · doi:10.1136/heartjnl-2012-301954 · Cited by 24
Metadata
- Authors
- Maciejewski, J. P., Selleri, C., Sato, T., Cho, H. J., Keefer, L. K., Nathan, C. F., & Young, N. S.
- Affiliations
- National Heart, Lung, and Blood Institute (US)
- National Institutes of Health (US)
- Cornell University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-08-01
- Volume
- 96
- Issue
- 2
- Pages
- 1085-1092
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC185297
- OpenAlex
- W2003571729
- Cited by
- 209
- References
- 62
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 2 · 2014: 8 · 2013: 3 · 2012: 8
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- nitric oxide, hematopoiesis inhibition, interferon-gamma, TNF-α, inducible nitric oxide synthase, CD34+ hematopoietic progenitor cells, bone marrow, apoptosis, L-NMMA, colony formation, long-term culture-initiating cells
- MeSH terms
- Amino Acid Oxidoreductases, Arginine, Base Sequence, Benzamides, Bone Marrow Cells, Cells, Cultured, Colony-Forming Units Assay, Enzyme Induction, Hematopoiesis, Hematopoietic Stem Cells, Humans, Interferon-gamma, Molecular Sequence Data, Nitric Oxide, RNA, Messenger, Tumor Necrosis Factor-alpha, Polymerase Chain Reaction, Apoptosis, Nitric Oxide Synthase, omega-N-Methylarginine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.